NOVOZYMES A/S SPONS.ADR 1 Logo
US6701081092
A0YF6B
NVZMY

NOVOZYMES A/S SPONS.ADR 1

Loading quotes...

Forecast

Buy
  0
Hold
  1
Sell
  1

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Novozymes raises guidance and launches €1bn share buyback after strong Q2 results

    Novozymes reported adjusted EBITDA of €419.2m for Q2 and organic growth of 9%, both above consensus estimates. The company raised its full‑year guidance and now expects organic sales growth of 7–8% and an adjusted EBITDA margin at the upper end of 37–38%. Novozymes also announced a €1bn share buyback program (start H2 2026, duration until 2029) and confirmed the acquisition of the remaining 77% of MicroBioGen. The news drove the share price markedly higher and pushed it to a new 52‑week high. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2026, NOVOZYMES A/S SPONS.ADR 1 has already paid €0.88 in dividends. The last payout was in September.

Financials

In the last quarter, NOVOZYMES A/S SPONS.ADR 1 had revenue of €1.14B and net profit of €187.9M
(EUR) September 2026
YoY
Revenue 1.14B 7.46%
Gross profit 647.3M 19.45%
Net profit 187.9M 36.73%
EBITDA 283.5M 14.51%

Fundamentals

Metric Value
Market capitalization
€28.74B
Number of shares
467.6M
52-week high/low
€68.38 - €45.33
Dividend yield
1.43%
Dividends TTM
€0.87
Beta
0.62
P/E ratio
40.92
PEG ratio
1.51
P/B ratio
2.57
P/S ratio
5.79

Company profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Name
NOVOZYMES A/S SPONS.ADR 1
CEO
Ester Baiget
Headquarters Lyngby, nd
USA
Website
IPO
01/20/2010
Employees 11,641

Ticker symbols

Exchange Symbol
Pnk
NVZMY
Frankfurt
NZM.F
Düsseldorf
NZM.DU
München
NZM.MU
🍪

Parqet  uses cookies. Learn more